<VariationArchive VariationID="1453870" VariationName="NM_024757.5(EHMT1):c.3579del (p.Asn1194fs)" VariationType="Deletion" Accession="VCV001453870" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1451396" VariationID="1453870">
      <GeneList>
        <Gene Symbol="EHMT1" FullName="euchromatic histone lysine methyltransferase 1" GeneID="79813" HGNC_ID="HGNC:24650" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9q34.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="137619005" stop="137836127" display_start="137619005" display_stop="137836127" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="140513443" stop="140730578" display_start="140513443" display_stop="140730578" Strand="+" />
          </Location>
          <OMIM>607001</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EHMT1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=EHMT1">Little evidence for dosage pathogenicity</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_024757.5(EHMT1):c.3579del (p.Asn1194fs)</Name>
      <CanonicalSPDI>NC_000009.12:137834384:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9q34.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="137834385" stop="137834385" display_start="137834385" display_stop="137834385" variantLength="1" positionVCF="137834384" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="140728837" stop="140728837" display_start="140728837" display_stop="140728837" variantLength="1" positionVCF="140728836" referenceAlleleVCF="CG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>N1187fs</ProteinChange>
      <ProteinChange>N1194fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.140728839del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.140728839del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_024757.5" sequenceAccession="NM_024757" sequenceVersion="5" change="c.3579del" MANESelect="true">
            <Expression>NM_024757.5:c.3579del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079033.4" sequenceAccession="NP_079033" sequenceVersion="4" change="p.Asn1194fs">
            <Expression>NP_079033.4:p.Asn1194fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.137834387del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.137834387del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011776.1" sequenceAccession="NG_011776" sequenceVersion="1" change="g.220396del">
            <Expression>NG_011776.1:g.220396del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354263.2" sequenceAccession="NM_001354263" sequenceVersion="2" change="c.3558del">
            <Expression>NM_001354263.2:c.3558del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341192.1" sequenceAccession="NP_001341192" sequenceVersion="1" change="p.Asn1187fs">
            <Expression>NP_001341192.1:p.Asn1187fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2133152290" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_024757.5(EHMT1):c.3579del (p.Asn1194fs) AND Kleefstra syndrome 1" Accession="RCV001941593" Version="3">
        <ClassifiedConditionList TraitSetID="948">
          <ClassifiedCondition DB="MedGen" ID="C0795833">Kleefstra syndrome 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-25" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-06-25" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">22670141</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="948" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2521" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Kleefstra syndrome 1</ElementValue>
                <XRef ID="MONDO:0027407" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Kleefstra syndrome is characterized by intellectual disability, autistic-like features, childhood hypotonia, and distinctive facial features. The majority of individuals function in the moderate-to-severe spectrum of intellectual disability although a few individuals have mild delay and total IQ within low-normal range. While most have severe expressive speech delay with little speech development, general language development is usually at a higher level, making nonverbal communication possible. A complex pattern of other findings can also be observed; these include heart defects, renal/urologic defects, genital defects in males, severe respiratory infections, epilepsyÂ / febrile seizures, psychiatric disorders, and extreme apathy or catatonic-like features after puberty.</Attribute>
                <XRef ID="NBK47079" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20945554</ID>
                <ID Source="BookShelf">NBK47079</ID>
              </Citation>
              <XRef ID="261494" DB="Orphanet" />
              <XRef ID="C0795833" DB="MedGen" />
              <XRef ID="MONDO:0027407" DB="MONDO" />
              <XRef Type="MIM" ID="610253" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4248315" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="13065281|MedGen:C0795833" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002230621" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22670141</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the protein in which other variant(s) (p.Arg1197Trp) have been observed in individuals with EHMT1-related conditions (PMID: 22670141). This suggests that this may be a clinically significant region of the EHMT1 protein. This variant has been observed in individual(s) with clinical features of EHMT1-related conditions (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Asn1194Thrfs*38) in the EHMT1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 105 amino acid(s) of the EHMT1 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EHMT1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.140728837del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0795833" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4248315" TraitType="Disease" MappingType="XRef" MappingValue="C0795833" MappingRef="MedGen">
        <MedGen CUI="C0795833" Name="Kleefstra syndrome 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

